Bio-Techne Corporation

NASDAQ:TECH

Biotechnology

Healthcare
$72.75 -1.84%

-$1.03 today

Market cap
$11.43B
Beta
1.36
P/E (TTM)
78.3
EPS (TTM)
$0.70
Dividend yield
0.58%
52W Low $43.20High $72.16

Volume 2.63M

Average 2.66M

TECH Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Bio-Techne CorporationNASDAQ: TECH

Weighted Avg Shares (Diluted) · Q1 FY2027 · quarter ended Sep 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q1 FY2027 weighted avg shares (diluted) of 157.93M shares rose 1.0% year over year, ahead of the -0.4% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at -1.0% a year.

Context

  • Weighted avg shares (diluted) increased in 0 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.0% holds above the trailing-twelve-month pace of -0.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
157.93M+0.6% QoQ
Last fiscal yearJun 2026
157.01M-1.7% YoY
LTMSep 2026
157.22M-0.4% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.0%——
1 year-1.7%——
3-year CAGR-1.0%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2026
157.01M USD
Year-over-year change
-1.7%
4-year CAGR
-1.1%

Weighted Avg Shares (Diluted) vs competitors

How TECH compares with its peers on the latest reported figures

  • TECH's LTM Sep 2026 weighted avg shares (diluted) of 157.22M shares is the 5th highest of the 11 companies compared; the peer median is 140.67M shares.
  • Its year-over-year change of -0.4% is the 3rd highest of 10, against a peer median of -1.9%.
  • Over three fiscal years its annual growth of -1.0% compares with a peer median of -1.8%.
TECH Competitors Peer median
Weighted Avg Shares (Diluted) for TECH and competitors
Company Period LTM YoY 3-year CAGR
DHRDanaher CorporationLTM Sep 2026709.15M -1.9%-1.2%
TMOThermo Fisher Scientific Inc.LTM Sep 2026373M -1.7%-1.5%
AAgilent Technologies, Inc.LTM Jul 2026283.75M -1.1%-1.8%
QGENQiagen N.V.LTM Jun 2026210.75M -4.3%-2.3%
TECHBio-Techne CorporationLTM Sep 2026157.22M -0.4%-1.0%
BRKRBruker CorporationLTM Jun 2026152.3M +0.3%+0.5%
TXG10x Genomics, Inc.LTM Sep 2026129.04M +4.4%+3.1%
RVTYRevvity, Inc.LTM Jul 2026113.64M -5.8%-3.6%
ALMRAlamar Biosciences, Inc.FY202566.52M ——
SEERSeer, Inc.LTM Mar 202656.96M -7.5%-2.7%
BIOBio-Rad Laboratories, Inc.LTM Jun 202626.93M -3.1%-2.9%
Peer median (excluding TECH) 140.67M-1.9%-1.8%

Competitors are the stored peer set for TECH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue1.11B1.14B1.16B1.22B1.22B
Cost of Revenue349.1M366.89M389.34M429.36M415.97M
Gross Profit756.5M769.82M769.73M790.27M799.07M
Gross Margin68.4%67.7%66.4%64.8%65.8%
Research & Development87.14M92.49M96.66M99.5M94.77M
Selling, General & Admin339M352.44M393.32M415.1M452.42M
Operating Expenses459.91M470.87M563.04M688.02M547.18M
Depreciation & Amortization101.07M107.24M111.71M109.9M97.36M
EBITDA413.76M457.11M313.14M216.88M343.44M
EBITDA Margin37.4%40.2%27.0%17.8%28.3%
Operating Income296.59M298.94M206.69M102.26M251.89M
Operating Margin26.8%26.3%17.8%8.4%20.7%
Interest Income794K3.41M3.32M3.89M0
Interest Expense11.31M11.22M15.74M8.51M5.41M
Other Income / Expenses4.8M39.72M(21M)(3.79M)(11.21M)
Income Before Tax301.39M338.66M185.69M98.46M240.68M
Pre-Tax Margin27.3%29.8%16.0%8.1%19.8%
Income Tax Expense38.29M53.22M17.58M25.06M58.82M
Net Income272.05M285.26M168.11M73.4M181.86M
Net Margin24.6%25.1%14.5%6.0%15.0%
EPS (Basic)1.731.811.070.471.17
EPS (Diluted)1.661.761.050.461.16
Weighted Avg Shares156.88M157.18M157.71M157.52M155.96M
Weighted Avg Shares (Diluted)164.12M161.86M160.77M159.72M157.01M

Bio-Techne Corporation

NASDAQ:TECH

Intrinsic Alpha fair value

Locked

Current Price

$72.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.